Company intelligence / Profile preview

Liaoning Oriental Pharmaceutical

Fushun, Liaoning, China
Ownership
Private
Development stage
Commercial
01

Overview

The name "Liaoning Oriental Pharmaceutical" does not appear as an exact standalone entity in available records. However, the broader pharmaceutical sector in Liaoning province includes several active manufacturers of generic drugs and APIs. These companies are involved in R&D and production, with some being targets for acquisition by multinational corporations, contributing to a growing biopharma industrial cluster.

Therapeutic areas
NephrologyOncologyEndocrinologyImmunologyGastroenterologyNeurology
Modalities
Small moleculesTabletsCapsulesOintmentsInjections
Industry
Biotech
02

Drug pipeline

4 assets

hemocoagulase atrox

Commercial
Indications
Perioperative blood loss

3 more assets in the full pipeline.

Request access →
03

Partnerships

Eisai's acquisition of Liaoning TianYi Biological Pharmaceuticals indicates a strategic expansion into the Chinese generics market.General local academic collaborations are reported within the region.

Beyond the preview

Go deeper on Liaoning Oriental Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Liaoning Oriental Pharmaceutical.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call